CBIO Competitors & Alternatives
Compare Crescent Biopharma, Inc. with similar stocks in the same industry
Biotechnology
CBIO
Main Stock$17.81
Tradestie Score
48
Market Cap
$199.71M
Analyst Upside
+74.1%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$3.05
|
$552.46M | - | 50 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.25
|
$540.97M | - | 61 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$12.57
|
$529.35M | 6.5 | 62 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.95
|
$512.39M | - | 51 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$33.64
|
$505.12M | 1.7 | 64 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$94.36
|
$492.21M | - | 51 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$42.19
|
$474.20M | 26.6 | 57 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.45
|
$468.01M | - | 56 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.28
|
$463.20M | - | 50 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.36
|
$457.09M | - | 57 | Compare |
More CBIO Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry